Study on Skin Toxicities Induced by Cancer Treatments

Korábbi kezelés

• Patient receiving anti-tumor treatment with radiotherapy exclusively or associated with concomitant radiotherapy ;

Más betegség

• Patient treated for lymphoma, leukemia or inflammatory breast cancer ;
• Patient with a general condition > 2 at baseline (ECOG classification) ;

Egyéb

• Patient with a solid tumour which location is other than breast or lung;
• Patient with a tumor wound ;
• Patient unable to receive information about the study and to give consent ;
• Persons deprived of liberty or guardianship ;
• Impossible submission to study procedures for geographical or psychological reasons.

• Patient, male or female, aged 18 years and older, with a solid tumor breast or lung, localized, locally advanced or not, metastatic or not;
• Patient in medical oncology consultation requiring systemic anti-tumor therapy (chemotherapy, targeted therapy, hormone therapy, immunotherapy) in neo-adjuvant, adjuvant or metastatic;
• Treatment planned for a minimum period of 3 months (from the date of inclusion);
• Having a social security protection;
• Signed informed consent form of the study.